Literature DB >> 27197101

[End stage renal disease lymphopenia; characterization and clinical correlation].

José Luis Lepe-Zúñiga1, Pedro Morales-Molina, Gabriela Alejandra García-Nandayapa.   

Abstract

BACKGROUND: Patients with End Stage Renal Disease (ESRD), defined as those in Stage 5 of the Kidney Disease Outcome Quality Initiative (KDOQI) classification, have a number of acquired immune deficiencies secondary to the uremic stage, among them lymphopenia. In the present report, we retrospectively characterized the peripheral blood lymphocyte counts in a group of patients with ESRD and we related lymphopenia to their biochemical parameters and to the presence or absence of infections.
METHODS: Medical records from 190 patients in ESRD were selected from 282 medical records of patients being treated between February 2008 and November 2012 for kidney failure at different stages. A number of variables, including lymphocyte counts, biochemical parameters and infections, were analyzed at two different time points: Before and during dialysis.
RESULTS: ESRD patients analyzed had a well defined peripheral blood hematological pattern, characterized by severe chronic anemia, normal or elevated leukocyte count and normal or below normal lymphocyte count. The degree of hematological changes correlated with the depth of renal dysfunction and improved with dialysis along with the improvement of urea and creatinine values.
CONCLUSIONS: Lymphopenia was present in around half ESRD patients and was associated with increased infections, but they were of the same type as those present in ESRD patients without lymphopenia. Infections were different as those commonly associated with other immune deficiency lymphopenias. The implications of these findings are discussed.

Entities:  

Keywords:  Chronic kidney failure; Chronic renal insufficiency; Lymphopenia; Uremia

Mesh:

Year:  2016        PMID: 27197101

Source DB:  PubMed          Journal:  Rev Med Inst Mex Seguro Soc        ISSN: 0443-5117


  1 in total

1.  Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis.

Authors:  Jacqueline Betsabe Puicón-Suárez; Sandra Zeña-Ñañez; Virgilio E Failoc-Rojas
Journal:  PeerJ       Date:  2022-06-14       Impact factor: 3.061

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.